Philip G. Janicak

8.4k total citations · 2 hit papers
133 papers, 5.9k citations indexed

About

Philip G. Janicak is a scholar working on Psychiatry and Mental health, Clinical Psychology and Neurology. According to data from OpenAlex, Philip G. Janicak has authored 133 papers receiving a total of 5.9k indexed citations (citations by other indexed papers that have themselves been cited), including 93 papers in Psychiatry and Mental health, 22 papers in Clinical Psychology and 22 papers in Neurology. Recurrent topics in Philip G. Janicak's work include Schizophrenia research and treatment (48 papers), Bipolar Disorder and Treatment (42 papers) and Electroconvulsive Therapy Studies (36 papers). Philip G. Janicak is often cited by papers focused on Schizophrenia research and treatment (48 papers), Bipolar Disorder and Treatment (42 papers) and Electroconvulsive Therapy Studies (36 papers). Philip G. Janicak collaborates with scholars based in United States, Australia and Japan. Philip G. Janicak's co-authors include Mark S. George, Mark A. Demitrack, John M. Davis, Shirlene Sampson, H. Brent Solvason, John P. O’Reardon, Colleen Loo, Rajiv P. Sharma, David Avery and Harold A. Sackeïm and has published in prestigious journals such as American Journal of Psychiatry, Biological Psychiatry and Journal of the American Academy of Child & Adolescent Psychiatry.

In The Last Decade

Philip G. Janicak

123 papers receiving 5.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Efficacy and Safety of Transcranial Magnetic Stimulation in the Acute Treatment of Major Depression: A Multisite Randomized Controlled Trial

2007 1.3k citations John P. O’Reardon, H. Brent Solvason et al. Biological Psychiatry profile →
The Clinical TMS Society Consensus Review and Treatment Recommendations for TMS Therapy for Major Depressive Disorder

2016 428 citations Mark S. George, Philip G. Janicak et al. Brain stimulation profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Philip G. Janicak United States	38	2.8k	2.6k	1.5k	960	802	133	5.9k
Mark A. Demitrack United States	43	3.2k 1.2×	2.2k 0.8×	1.6k 1.1×	1.2k 1.2×	2.2k 2.8×	119	7.9k
David Avery United States	36	1.8k 0.7×	2.9k 1.1×	2.0k 1.3×	994 1.0×	1.1k 1.4×	89	6.2k
Leon Grunhaus Israel	33	1.4k 0.5×	1.5k 0.6×	1.1k 0.7×	799 0.8×	882 1.1×	130	4.4k
John P. O’Reardon United States	39	1.7k 0.6×	2.8k 1.1×	1.9k 1.3×	2.4k 2.5×	1.0k 1.3×	94	7.0k
Shawn M. McClintock United States	36	2.6k 1.0×	1.9k 0.7×	1.6k 1.0×	732 0.8×	2.0k 2.5×	128	5.4k
S. Craig Risch United States	38	1.2k 0.4×	1.1k 0.4×	1.2k 0.8×	435 0.5×	692 0.9×	132	4.7k
Alkomiet Hasan Germany	42	2.3k 0.8×	2.0k 0.8×	1.9k 1.3×	1.1k 1.2×	594 0.7×	215	6.1k
Mustafa M. Husain United States	55	4.5k 1.6×	3.6k 1.4×	2.5k 1.6×	1.2k 1.3×	3.6k 4.6×	179	10.5k
Cheng‐Ta Li Taiwan	47	2.3k 0.8×	1.2k 0.5×	2.4k 1.5×	941 1.0×	2.0k 2.4×	236	7.3k
Daniel M. Blumberger Canada	48	2.7k 1.0×	4.8k 1.9×	4.6k 3.0×	1.2k 1.3×	1.9k 2.4×	364	9.6k

Countries citing papers authored by Philip G. Janicak

Since Specialization

Citations

This map shows the geographic impact of Philip G. Janicak's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Philip G. Janicak with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Philip G. Janicak more than expected).

Fields of papers citing papers by Philip G. Janicak

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Philip G. Janicak. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Philip G. Janicak. The network helps show where Philip G. Janicak may publish in the future.

Co-authorship network of co-authors of Philip G. Janicak

This figure shows the co-authorship network connecting the top 25 collaborators of Philip G. Janicak. A scholar is included among the top collaborators of Philip G. Janicak based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Philip G. Janicak. Philip G. Janicak is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Janicak, Philip G., et al.. (2016). Advances in Transcranial Magnetic Stimulation for Managing Major Depressive Disorders: The Utility of TMS for Treating Depression Continues to Widen, as the Technology Is Refined. Current psychiatry. 15(6). 49. 3 indexed citations

Philip, Noah S., David L. Dünner, Sheila M. Dowd, et al.. (2015). Can Medication Free, Treatment-Resistant, Depressed Patients Who Initially Respond to TMS Be Maintained Off Medications? A Prospective, 12-Month Multisite Randomized Pilot Study. Brain stimulation. 9(2). 251–257. 53 indexed citations

Janicak, Philip G. & Mehmet E. Dokucu. (2015). Transcranial magnetic stimulation for the treatment of major depression. Neuropsychiatric Disease and Treatment. 11. 1549–1549. 83 indexed citations

Janicak, Philip G. & Jeffrey Rado. (2012). Quetiapine for the treatment of acute bipolar mania, mixed episodes and maintenance therapy. Expert Opinion on Pharmacotherapy. 13(11). 1645–1652. 7 indexed citations

Janicak, Philip G., Ziad Nahas, Sarah H. Lisanby, et al.. (2010). Durability of clinical benefit with transcranial magnetic stimulation (TMS) in the treatment of pharmacoresistant major depression: assessment of relapse during a 6-month, multisite, open-label study. Brain stimulation. 3(4). 187–199. 117 indexed citations

Janicak, Philip G.. (2010). Transcranial magnetic stimulation for major depressive disorder: introduction.. PubMed. 22(4 Suppl). S3–S3. 1 indexed citations

Pavuluri, Mani N. & Philip G. Janicak. (2009). Handbook of psychopharmacotherapy : a life-span approach. 1 indexed citations

Avery, David, K E Isenberg, Shirlene Sampson, et al.. (2008). Transcranial Magnetic Stimulation in the Acute Treatment of Major Depressive Disorder. The Journal of Clinical Psychiatry. 69(3). 441–451. 108 indexed citations

Janicak, Philip G., John P. O’Reardon, Shirlene Sampson, et al.. (2008). Transcranial Magnetic Stimulation in the Treatment of Major Depressive Disorder. The Journal of Clinical Psychiatry. 69(2). 222–232. 160 indexed citations

10.

O’Reardon, John P., H. Brent Solvason, Philip G. Janicak, et al.. (2007). Efficacy and Safety of Transcranial Magnetic Stimulation in the Acute Treatment of Major Depression: A Multisite Randomized Controlled Trial. Biological Psychiatry. 62(11). 1208–1216. 1282 indexed citations breakdown →

11.

Rado, Jeffrey, Sheila M. Dowd, & Philip G. Janicak. (2007). Paliperidone ER: Reformulated Antipsychotic for Schizophrenia Tx; Risperidone's Metabolite Behaves Well but Differently in Once-Daily Delivery. Current psychiatry. 6(9). 75. 1 indexed citations

12.

Pavuluri, Mani N., et al.. (2006). AOne-Year Open-Label Trial of Risperidone Augmentation in Lithium Nonresponder Youth with Preschool-Onset Bipolar Disorder. Journal of Child and Adolescent Psychopharmacology. 16(3). 336–350. 52 indexed citations

13.

Martis, Brian, Danesh Alam, Sheila M. Dowd, et al.. (2003). Neurocognitive effects of repetitive transcranial magnetic stimulation in severe major depression. Clinical Neurophysiology. 114(6). 1125–1132. 98 indexed citations

14.

Pavuluri, Mani N., Philip G. Janicak, Michael W. Naylor, & John A. Sweeney. (2003). Early Recognition and Differentiation of Pediatric Schizophrenia and Bipolar Disorder. 27. 117–134. 3 indexed citations

15.

Negrusz, Adam, et al.. (2003). Elimination of 7-aminoclonazepam in urine after a single dose of clonazepam. Analytical and Bioanalytical Chemistry. 376(8). 1198–1204. 16 indexed citations

16.

Ren, Xinguo, et al.. (2001). Hyperactive phosphoinositide signaling pathway in platelets of depressed patients: effect of desipramine treatment. Psychiatry Research. 105(1-2). 23–32. 15 indexed citations

17.

Negrusz, Adam, et al.. (2001). Deposition of 7-Aminoflunitrazepam and Flunitrazepam in Hair After a Single Dose of Rohypnol®. Journal of Forensic Sciences. 46(5). 1143–1151. 50 indexed citations

18.

Marder, Stephen R., John M. Davis, & Philip G. Janicak. (1993). Clinical use of neuroleptic plasma levels. 6 indexed citations

19.

Pandey, Ghanshyam N., Subhash C. Pandey, Philip G. Janicak, Robert Marks, & John M. Davis. (1990). Platelet serotonin-2 receptor binding sites in depression and suicide. Biological Psychiatry. 28(3). 215–222. 181 indexed citations

20.

Janicak, Philip G., et al.. (1980). The Borderland of Autonomy: Medical-Legal Criteria for Capacity to Consent. The Journal of Psychiatry & Law. 8(4). 361–387. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact